Physical Characterization and Formulation Development of a Recombinant Pneumolysoid Protein-Based Pneumococcal Vaccine
Pneumolysin is a protein toxin produced by virtually all invasive strains of S. pneumoniae and is considered an important virulence factor. It is immunogenic and has the potential to be a new vaccine antigen offering broad serotype-independent coverage protecting against pneumococcal disease. This article, published in the Journal of Pharmaceutical Sciences, provides preformulation characterization results of a recombinant pneumolysin mutant (pneumolysoid L460D), information useful for the development of a stable pneumolysin mutant-based pneumococcal vaccine. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)
Author(s): Hu L, Joshi SB, Liyanage MR, et al.
Visit web page (English)
(Located at onlinelibrary.wiley.com)
Citation: Hu L, Joshi SB, Liyanage MR, et al. Physical Characterization and Formulation Development of a Recombinant Pneumolysoid Protein-Based Pneumococcal Vaccine. Journal of Pharmaceutical Sciences. 2013;102(2):387-400.